seed
Stage
1
Investors
About
ExpressionEdits develops AI-driven genetic syntax optimization technology that uses patented intronization to enhance gene expression, enabling efficient production of complex therapeutic proteins and advancing cell and gene therapy applications.
Explore expressionedits's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.